HES1 and non-small cell lung carcinoma: Six studies including a total of 1087 patients demonstrated that HES1 overexpression was statistically associated with the overall survival rate of NSCLC patients (pooled HR = 1.77, 95%CI: 1.35-2.31, p = 0.489 and I2 = 0.0%) (Fig. 6A).